๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Retinal Dystrophies

Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy NCT07656753EARLY Phase 11 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: PUMCH-E111 Injection๏ผˆLow dose๏ผ‰, PUMCH-E111 Injection๏ผˆHigh dose๏ผ‰ Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) NCT06445322n/a9 sites๐Ÿ“ San Francisco๐Ÿ“ Gainesville๐Ÿ“ Baltimore Ascidian Therapeutics, Inc ยท Tests: Prescreening Assessments VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies NCT04648124n/a1 site๐Ÿ“ Paris Fondation Ophtalmologique Adolphe de Rothschild ยท Tests: IRMf-r (sรฉquence resting state) BS01 in Patients With Retinitis Pigmentosa NCT04278131Phase 1, Phase 21 site๐Ÿ“ Teaneck Bionic Sight LLC ยท Tests: BS01 Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics NCT00001373n/a5 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore๐Ÿ“ Bethesda National Human Genome Research Institute (NHGRI) Safety of Cultured Allogeneic Adult Umbilical Cord or Placental Derived Mesenchymal Stem Cell Exosomes for NAION NCT05147701Phase 12 sites๐Ÿ“ Naples๐Ÿ“ Athens The Foundation for Orthopaedics and Regenerative Medicine ยท Tests: cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cell exosomes A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa NCT06628947Phase 25 sites๐Ÿ“ Sydney๐Ÿ“ Woolloongabba๐Ÿ“ Adelaide Kiora Pharmaceuticals, Inc. ยท Tests: Placebo (Sterile Saline or Balanced Salt Solution), 100 ฮผg KIO-301, 50 ฮผg KIO-301 Cell Collection to Study Eye Diseases NCT01432847n/a1 site๐Ÿ“ Bethesda National Eye Institute (NEI) A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) NCT06942572Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Miami๐Ÿ“ Boston Splice Bio ยท Tests: SB-007 Inherited Retinal Degenerative Disease Registry NCT02435940n/a1 site๐Ÿ“ Columbia Foundation Fighting Blindness Natural History Study of Inherited Retinal Diseases NCT07085533n/a1 site๐Ÿ“ Wuhan Zhongmou Therapeutics Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease NCT04289571Phase 12 sites๐Ÿ“ Bethesda๐Ÿ“ Sydney National Eye Institute (NEI) ยท Tests: VR Mobility Tool EyeConic: Qualification for Cone-Optogenetics NCT05294978n/a9 sites๐Ÿ“ San Francisco๐Ÿ“ Miami๐Ÿ“ Pittsburgh Institute of Molecular and Clinical Ophthalmology Basel ยท Tests: Optical coherence tomography (OCT) Adaptive Optics Imaging of Outer Retinal Diseases NCT05355415n/a2 sites๐Ÿ“ Bethesda๐Ÿ“ Silver Spring Food and Drug Administration (FDA) ยท Tests: Adaptive optics imaging Implementation and Evaluation of a Post-Diagnostic Announcement Protocol at the CRMR RefeRet, Quinze-Vingts Hospital NCT07292987NA1 site๐Ÿ“ Paris Centre Hospitalier National d'Ophtalmologie des Quinze-Vingโ€ฆ ยท Tests: Enhanced post-diagnostic support, Usual Care Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases NCT00874783n/a1 site๐Ÿ“ Jerusalem Hadassah Medical Organization Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation NCT06952842Phase 1, Phase 21 site๐Ÿ“ Beijing Chigenovo Co., Ltd ยท Tests: ZVS203e A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome NCT07710196Phase 31 site๐Ÿ“ Dallas Nacuity Pharmaceuticals, Inc. ยท Tests: Placebo, NPI-001 The Effects of Disulfiram (Antabuseยฎ) on Visual Acuity in Patients With Retinal Degeneration NCT06319872Phase 11 site๐Ÿ“ Rochester University of Rochester ยท Tests: Oral disulfiram Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa NCT06242379Phase 1, Phase 21 site๐Ÿ“ Bangkok Noi Mahidol University ยท Tests: GMP compliant-BM-MSC derived sEVs Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants NCT05589714n/a36 sites๐Ÿ“ Little Rock๐Ÿ“ Los Angeles๐Ÿ“ San Francisco Jaeb Center for Health Research Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer NCT02014389n/a1 site๐Ÿ“ Tel Litwinsky Sheba Medical Center Disulfiram for Treatment of Retinal Degeneration NCT05626920Phase 1, Phase 21 site๐Ÿ“ Seattle University of Washington ยท Tests: Disulfiram 250 mg, Placebo Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene NCT06291935Phase 11 site๐Ÿ“ Tรผbingen VeonGen Therapeutics GmbH ยท Tests: VG901 A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa NCT06891885Phase 1, Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Minneapolis Sumitomo Pharma America, Inc. ยท Tests: DSP-3077 Retinal Sheet Cohort 1, DSP-3077 Retinal Sheet Cohort 2, DSP-3077 Retinal Sheet Cohort 3 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites๐Ÿ“ Sioux Falls๐Ÿ“ Sydney Sanford Health Safety and Efficacy Study of Novel Gene Therapy ZM-02 for Retinitis Pigmentosa Patients NCT06292650EARLY Phase 11 site๐Ÿ“ Beijing Zhongmou Therapeutics ยท Tests: ZM-02-L, ZM-02-H, ZM-02-S Evaluating a New Peptide Therapy for Retinal Diseases: AMD, Diabetic Retinopathy, and Dystrophies NCT06787482Phase 1, Phase 22 sites๐Ÿ“ Cairo๐Ÿ“ Giza Ace Cells Lab Limited ยท Tests: ACE Retino Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB) NCT07185256Phase 1, Phase 25 sites๐Ÿ“ Los Angeles๐Ÿ“ Gainsville๐Ÿ“ New York Opus Genetics, Inc ยท Tests: OPGx-BEST1 Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease) NCT07002398Phase 1, Phase 21 site๐Ÿ“ Shanghai VeonGen Therapeutics GmbH ยท Tests: VG801
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy